Michele Colledan
Michele Colledan
Director, Department of Surgery Ospedale Giovanni XXIII, Bergamo, Italy
Verified email at asst-pg23.it
Cited by
Cited by
The hemolytic uremic syndrome
G Remuzzi, P Ruggenenti
Kidney international 48 (1), 2-19, 1995
Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial
EK Geissler, AA Schnitzbauer, C ZŘlke, PE Lamby, A Proneth, C Duvoux, ...
Transplantation 100 (1), 116, 2016
Patterns of hepatitis delta virus reinfection and disease in liver transplantation
A Ottobrelli, A Marzano, A Smedile, S Recchia, M Salizzoni, C Cornu, ...
Gastroenterology 101 (6), 1649-1655, 1991
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation forá…
AA Schnitzbauer, C Zuelke, C Graeb, J Rochon, I Bilbao, P Burra, ...
BMC cancer 10 (1), 1-8, 2010
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling
L Fabris, M Cadamuro, M Guido, C Spirli, R Fiorotto, M Colledan, G Torre, ...
The American journal of pathology 171 (2), 641-653, 2007
Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation
G Remuzzi, P Ruggenenti, M Colledan, B Gridelli, A Bertani, P Bettinaglio, ...
American Journal of Transplantation 5 (5), 1146-1150, 2005
Platelet‐derived growth factor‐D and Rho GTPases regulate recruitment of cancer‐associated fibroblasts in cholangiocarcinoma
M Cadamuro, G Nardo, S Indraccolo, L Dall'Olmo, L Sambado, L Moserle, ...
Hepatology 58 (3), 1042-1053, 2013
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
A Notarpaolo, R Layese, P Magistri, M Gambato, M Colledan, G Magini, ...
Journal of hepatology 66 (3), 552-559, 2017
Split and whole liver transplantation outcomes: a comparative cohort study
M Cardillo, N De Fazio, P Pedotti, T De Feo, LR Fassati, V Mazzaferro, ...
Liver transplantation 12 (3), 402-410, 2006
2018 Annual Report of the European Liver Transplant Registry (ELTR)–50‐year evolution of liver transplantation
R Adam, V Karam, V Cailliez, JG O Grady, D Mirza, D Cherqui, ...
Transplant International 31 (12), 1293-1317, 2018
Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease
B Gridelli, M Spada, W Petz, A Bertani, A Lucianetti, M Colledan, ...
Transplantation 75 (8), 1197-1203, 2003
Monogenic diseases that can be cured by liver transplantation
S Fagiuoli, E Daina, L D’Antiga, M Colledan, G Remuzzi
Journal of hepatology 59 (3), 595-612, 2013
Nuclear expression of S100A4 calcium‐binding protein increases cholangiocarcinoma invasiveness and metastasization
L Fabris, M Cadamuro, L Moserle, J Dziura, X Cong, L Sambado, G Nardo, ...
Hepatology 54 (3), 890-899, 2011
A new splitting technique for liver grafts
M Colledan, E Andorno, U Valente, B Gridelli
The Lancet 353 (9166), 1763, 1999
Extensive use of split liver for pediatric liver transplantation: a single-center experience
M Spada, B Gridelli, M Colledan, A Segalin, A Lucianetti, W Petz, S Riva, ...
Liver Transplantation 6 (4), 415-428, 2000
Balancing donor and recipient risk factors in liver transplantation: the value of D‐MELD with particular reference to HCV recipients
AW Avolio, U Cillo, M Salizzoni, L De Carlis, M Colledan, GE Gerunda, ...
American Journal of Transplantation 11 (12), 2724-2736, 2011
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, RR Morales, L De Carlis, ...
Journal of hepatology 60 (2), 290-297, 2014
Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression
M Spada, W Petz, A Bertani, S Riva, A Sonzogni, M Giovannelli, E Torri, ...
American Journal of Transplantation 6 (8), 1913-1921, 2006
Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study
G Gerna, F Baldanti, M Torsellini, L Minoli, M Vigan˛, T Oggionni, ...
Antiviral therapy 12 (1), 63-72, 2007
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation—the European Liver Transplant Registry experience
G Orlando, R Adam, D Mirza, G Soderdahl, RJ Porte, A Paul, ...
Transplantation 95 (6), 872-877, 2013
The system can't perform the operation now. Try again later.
Articles 1–20